Tim Pool @Timcast
@Svinhuvud @DanOhta which is normal in clinical trials This means it should not be used to guide clinical practices until reviewed by the FDA the same is true of the Merck studies on molnupavir So the question is, why not EUA filing for ivermectin? EUA is specifically for this situation — PolitiTweet.org
